Wells Fargo & Company MN Sells 14,853 Shares of Azenta, Inc. (NASDAQ:AZTA)

Wells Fargo & Company MN lessened its holdings in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 6.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 221,145 shares of the company's stock after selling 14,853 shares during the quarter. Wells Fargo & Company MN owned about 0.48% of Azenta worth $11,057,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently bought and sold shares of the company. KLP Kapitalforvaltning AS purchased a new position in Azenta during the 4th quarter valued at about $530,000. State of Alaska Department of Revenue lifted its position in Azenta by 355.2% during the fourth quarter. State of Alaska Department of Revenue now owns 25,899 shares of the company's stock valued at $1,294,000 after purchasing an additional 20,210 shares during the last quarter. Stephens Inc. AR purchased a new position in Azenta in the 4th quarter worth approximately $313,000. Thrivent Financial for Lutherans increased its holdings in shares of Azenta by 206.5% in the 4th quarter. Thrivent Financial for Lutherans now owns 35,223 shares of the company's stock worth $1,761,000 after buying an additional 23,731 shares during the last quarter. Finally, SG Americas Securities LLC purchased a new stake in shares of Azenta during the 4th quarter valued at $813,000. 99.08% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. Needham & Company LLC increased their target price on Azenta from $55.00 to $59.00 and gave the company a "buy" rating in a research note on Thursday, February 6th. Evercore ISI boosted their price objective on shares of Azenta from $50.00 to $52.00 and gave the stock an "in-line" rating in a report on Thursday, February 6th. TD Cowen raised shares of Azenta to a "hold" rating in a report on Thursday, February 27th. Finally, Stephens reissued an "overweight" rating and issued a $60.00 price target on shares of Azenta in a research note on Thursday, January 2nd.

Azenta Stock Performance

NASDAQ:AZTA traded down $0.25 during midday trading on Friday, reaching $25.25. 880,637 shares of the stock traded hands, compared to its average volume of 639,401. The stock has a market capitalization of $1.15 billion, a P/E ratio of -8.47 and a beta of 1.66. Azenta, Inc. has a 12 month low of $24.68 and a 12 month high of $63.58. The company has a fifty day moving average of $36.94 and a 200 day moving average of $43.94.

Azenta (NASDAQ:AZTA - Get Free Report) last posted its earnings results on Wednesday, February 5th. The company reported $0.08 earnings per share for the quarter, topping analysts' consensus estimates of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. On average, analysts predict that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.